1. Home
  2. RVMDW vs MTH Comparison

RVMDW vs MTH Comparison

Compare RVMDW & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMDW
  • MTH
  • Stock Information
  • Founded
  • RVMDW N/A
  • MTH 1985
  • Country
  • RVMDW United States
  • MTH United States
  • Employees
  • RVMDW 490
  • MTH N/A
  • Industry
  • RVMDW
  • MTH Homebuilding
  • Sector
  • RVMDW
  • MTH Consumer Discretionary
  • Exchange
  • RVMDW Nasdaq
  • MTH Nasdaq
  • Market Cap
  • RVMDW N/A
  • MTH 6.9B
  • IPO Year
  • RVMDW N/A
  • MTH 1988
  • Fundamental
  • Price
  • RVMDW $0.18
  • MTH $151.54
  • Analyst Decision
  • RVMDW
  • MTH Hold
  • Analyst Count
  • RVMDW 0
  • MTH 9
  • Target Price
  • RVMDW N/A
  • MTH $193.71
  • AVG Volume (30 Days)
  • RVMDW N/A
  • MTH 495.2K
  • Earning Date
  • RVMDW N/A
  • MTH 01-29-2025
  • Dividend Yield
  • RVMDW N/A
  • MTH 1.95%
  • EPS Growth
  • RVMDW N/A
  • MTH 2.15
  • EPS
  • RVMDW N/A
  • MTH 22.10
  • Revenue
  • RVMDW N/A
  • MTH $6,433,727,000.00
  • Revenue This Year
  • RVMDW N/A
  • MTH $4.39
  • Revenue Next Year
  • RVMDW N/A
  • MTH $8.35
  • P/E Ratio
  • RVMDW N/A
  • MTH $6.96
  • Revenue Growth
  • RVMDW N/A
  • MTH N/A
  • 52 Week Low
  • RVMDW N/A
  • MTH $147.77
  • 52 Week High
  • RVMDW N/A
  • MTH $213.98
  • Technical
  • Relative Strength Index (RSI)
  • RVMDW N/A
  • MTH 33.78
  • Support Level
  • RVMDW N/A
  • MTH $150.94
  • Resistance Level
  • RVMDW N/A
  • MTH $157.31
  • Average True Range (ATR)
  • RVMDW 0.00
  • MTH 4.24
  • MACD
  • RVMDW 0.00
  • MTH -0.49
  • Stochastic Oscillator
  • RVMDW 0.00
  • MTH 19.18

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, which are comprised of ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments; homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes and providing warranty and customer services and the financial services segment offer title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

Share on Social Networks: